Chemical biology screen for prostate cancer therapeutics: Dissertation

Keyphrases

• Prostate Cancer 100%
• Cancer Therapeutics 100%
• Monensin 100%
• Chemical Biology 100%
• Prostate Cancer Cells 50%
• Salinomycin 50%
• Disulfiram 50%
• Small Molecules 25%
• Clinical Trials 25%
• Aldehyde Dehydrogenase 2 (ALDH2) 25%
• Cancer Cell Growth 25%
• High-throughput Screening 25%
• Prostate Epithelial Cells 25%
• Androgen Signaling 25%
• Cancer Treatment 25%
• Induced Oxidative Stress 25%
• Fungicide 25%
• Ionophore 25%
• Therapeutic Agents 25%
• Treatment Options 25%
• Cell Differentiation 25%
• Nonmalignant 25%
• Cellular Sensitivity 25%
• Histone Deacetylase Inhibitor (HDACi) 25%
• Thiram 25%
• Anti-androgen Therapy 25%
• Oxidative Stress 25%
• Aldehyde Dehydrogenase Activity 25%
• Antibiotics 25%
• Steroidogenesis 25%
• Cancer Stem Cells 25%
• Cancer Biology 25%
• Nanomolar Concentrations 25%
• Drug-like 25%
• Novel Treatments 25%

INIS

• biology 100%
• screens 100%
• cancer 100%
• prostate 100%
• drugs 30%
• growth 20%
• oxidation 20%
• dehydrogenases 20%
• aldehydes 20%
• androgens 20%
• levels 10%
• stem cells 10%
• concentration 10%
• molecules 10%
• sensitivity 10%
• clinical trials 10%
• antibiotics 10%
• receptors 10%
• cell differentiation 10%
• hormones 10%
• therapeutic agents 10%
• fungicides 10%
• histones 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Malignant Neoplasm 66%
• Monensin 66%
• Disulfiram 50%
• Salinomycin 33%
• Ionophore 16%
• Thiram 16%
• Clinical Trial 16%
• Androgen Receptor 16%
• Cancer Growth 16%
• Antiandrogen 16%
• Aldehyde Dehydrogenase Inhibitor 16%
• Histone Deacetylase Inhibitor 16%
• Aldehyde Dehydrogenase 16%
• Fungicide 16%